UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The tumor microenvironment shapes hallmarks of mature B-cell malignancies

Oncogene, 2015-09, Vol.34 (36), p.4673-4682

2015

Volltextzugriff (PDF)

An architecture for integrating planar and 3D cQED devices

Applied physics letters, 2016-07, Vol.109 (4)

2016

Volltextzugriff (PDF)

The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies

Oncogene, 2014-08, Vol.33 (32), p.4107-4113

2014

Volltextzugriff (PDF)

Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma

Oncogene, 2016-05, Vol.35 (21), p.2723-2734

2016

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.296-297

2015

Volltextzugriff (PDF)

Signatures of long-range-correlated disorder in the magnetotransport of ultrathin topological insulators

Physical review. B, 2018-12, Vol.98 (21), p.1, Article 214203

2018

Volltextzugriff (PDF)

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria

Leukemia, 2011-02, Vol.25 (2), p.379-382

2011

Volltextzugriff (PDF)

220 Overcoming drug-resistance in multiple myeloma by XPO1 inhibitor combination therapy

European journal of cancer (1990), 2014-11, Vol.50, p.74-75

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1179-1184

2013

Volltextzugriff (PDF)

IBRUTINIB FOR THE TREATMENT OF BING‐NEEL SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.183-184

2019

Volltextzugriff (PDF)

High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.148-149

2014

Volltextzugriff (PDF)

Logarithmic singularities and quantum oscillations in magnetically doped topological insulators

Physical review. B, 2018-02, Vol.97 (8), Article 085151

2018

Volltextzugriff (PDF)

Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR

Molecular cancer therapeutics, 2001-11, Vol.1 (1), p.69-78

2001

Volltextzugriff (PDF)

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation

Blood cancer journal (New York), 2012-03, Vol.2 (3), p.e63-e63

2012

Volltextzugriff (PDF)

Histone deacetylase 11 (HDAC11) is critical for plasma cell development and multiple myeloma survival

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e222-e223

2015

Volltextzugriff (PDF)

Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (8), p.3276-3280

2001

Volltextzugriff (PDF)

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Nature medicine, 2004-01, Vol.10 (1), p.48-54

2004

Volltextzugriff (PDF)

Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S206-S207

2024

Volltextzugriff (PDF)

Genotypic and phenotypic comparisons of de Novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7900-7906

2003

Volltextzugriff (PDF)

Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation

Blood, 1999-07, Vol.94 (1), p.265-274

1999

Volltextzugriff (PDF)

Clonal variability in CD95 expression is the major determinant in fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

Leukemia, 2000-05, Vol.14 (5), p.830-840

2000

Volltextzugriff (PDF)

The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance

Current opinion in oncology, 2000-11, Vol.12 (6), p.557-563

2000

Volltextzugriff (PDF)

Optimization of process variables for instant preparation of neyyappam like product and extension of shelf-life

Journal of food science and technology, 2013-10, Vol.50 (5), p.993-999

2013

Volltextzugriff (PDF)

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutation

Blood cancer journal (New York), 2012-03, Vol.2 (3), p.e63-e63

2012

Volltextzugriff (PDF)

Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects

The Journal of immunology (1950), 2005-04, Vol.174 (7), p.3925-3931

2005

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(214)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(295)
Russisch
(2)
Finnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(162)
Humans
(109)
Biological And Medical Sciences
(64)
Male
(55)
Female
(54)
Animals
(50)
Medical Sciences
(42)
Adolescent
(35)
Adult
(35)
Neurosciences & Neurology
(30)
Oncology
(30)
Biochemistry & Molecular Biology
(26)
Pediatrics
(25)
Clinical Neurology
(23)
Middle Aged
(23)
Rats
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Physical Sciences
(20)
Technology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The tumor microenvironment shapes hallmarks of mature B-cell malignancies

An architecture for integrating planar and 3D cQED devices

The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies

Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma

Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome

Signatures of long-range-correlated disorder in the magnetotransport of ultrathin topological insulators

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria

220 Overcoming drug-resistance in multiple myeloma by XPO1 inhibitor combination therapy

Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma

IBRUTINIB FOR THE TREATMENT OF BING‐NEEL SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY

High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation

Logarithmic singularities and quantum oscillations in magnetically doped topological insulators

Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation

Histone deacetylase 11 (HDAC11) is critical for plasma cell development and multiple myeloma survival

Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

Genotypic and phenotypic comparisons of de Novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model

Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation

Clonal variability in CD95 expression is the major determinant in fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance

Optimization of process variables for instant preparation of neyyappam like product and extension of shelf-life

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutation

Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects

Suchergebnisse filtern